Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $0 for the 12-month period ending 2015-12-26, per its 10-K filed 2016-02-12.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2016-02-12

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2015-12-26 was $0.00.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2015-09-26 was $0.00.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2015-06-27 was $0.00.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2015-03-28 was $0.00.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2015 was $0.00.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2014 was -$105.00K.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2013 was -$197.00K, a 301.02% decline from fiscal 2012.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2012 was $98.00K.
Period endOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 monthOther Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month as first filed
2015-12-26$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$0.00
derived: sum of 2 quarters · filed 2016-02-12
$0.00
derived: sum of 3 quarters · filed 2016-02-12
$0.00
10-K · filed 2016-02-12
2015-09-26$0.00
10-Q · filed 2015-11-04
$0.00
derived: sum of 2 quarters · filed 2015-11-04
$0.00
10-Q · filed 2015-11-04
$0.00
derived: sum of 4 quarters · filed 2016-02-12
2015-06-27$0.00
10-Q · filed 2015-07-30
$0.00
10-Q · filed 2015-07-30
$0.00
derived: sum of 3 quarters · filed 2016-02-12
$0.00
derived: sum of 4 quarters · filed 2016-02-12
2015-03-28$0.00
10-Q · filed 2015-04-30
$0.00
derived: sum of 2 quarters · filed 2016-02-12
$0.00
derived: sum of 3 quarters · filed 2016-02-12
$0.00
derived: sum of 4 quarters · filed 2016-02-12
2014-12-27$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$0.00
derived: sum of 2 quarters · filed 2016-02-12
$0.00
derived: sum of 3 quarters · filed 2016-02-12
-$105.00K
10-K · filed 2016-02-12
2014-09-27$0.00
10-Q · filed 2015-11-04
$0.00
derived: sum of 2 quarters · filed 2015-11-04
-$105.00K
10-Q · filed 2015-11-04
-$344.00K
derived: sum of 4 quarters · filed 2015-11-04
2014-06-28$0.00
10-Q · filed 2015-07-30
-$105.00K
10-Q · filed 2015-07-30
-$344.00K
derived: sum of 3 quarters · filed 2015-07-30
-$959.00K
derived: sum of 4 quarters · filed 2015-07-30
2014-03-29-$105.00K
10-Q · filed 2015-04-30
-$344.00K
derived: sum of 2 quarters · filed 2015-04-30
-$959.00K
derived: sum of 3 quarters · filed 2015-04-30
-$964.00K
derived: sum of 4 quarters · filed 2015-04-30
2013-12-28-$239.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
-$854.00K
derived: sum of 2 quarters · filed 2015-02-17
-$859.00K
derived: sum of 3 quarters · filed 2015-02-17
-$197.00K
10-K · filed 2015-02-17
$197.00K
10-K · filed 2014-02-25
2013-09-28-$615.00K
10-Q · filed 2014-10-30
-$620.00K
derived: sum of 2 quarters · filed 2014-10-30
$42.00K
10-Q · filed 2014-10-30
$238.00K
derived: sum of 4 quarters · filed 2014-10-30
2013-06-29-$5.00K
10-Q · filed 2014-08-07
$656.00K
10-Q · filed 2014-08-07
$853.00K
derived: sum of 3 quarters · filed 2014-08-07
$793.00K
derived: sum of 4 quarters · filed 2014-08-07
2013-03-30$662.00K
10-Q · filed 2014-04-30
$858.00K
derived: sum of 2 quarters · filed 2014-04-30
$798.00K
derived: sum of 3 quarters · filed 2014-04-30
$849.00K
derived: sum of 4 quarters · filed 2014-04-30
2012-12-29$196.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$136.00K
derived: sum of 2 quarters · filed 2014-02-25
$187.00K
derived: sum of 3 quarters · filed 2014-02-25
$98.00K
10-K · filed 2014-02-25
2012-09-29-$60.00K
10-Q · filed 2013-10-30
-$9.00K
derived: sum of 2 quarters · filed 2013-10-30
-$98.00K
10-Q · filed 2013-10-30
2012-06-30$51.00K
10-Q · filed 2013-07-31
-$38.00K
10-Q · filed 2013-07-31
2012-03-31-$89.00K
10-Q · filed 2013-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71